Page 11 - Michael Polyviou News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ’One ... Microbot MedicalFebruary 4, 2021 GMT HINGHAM, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received official notification from the Japan Patent Office (JPO) that it intends to grant the Company a patent for its ‘One & Done’ guidewire technology for use with endoluminal interventions. Japan is the second jurisdiction to grant a patent for the ‘One & Done’ ...

Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt HINGHAM, Mass., Jan. 27, 2021 — Microbot Medical Inc. (Nasdaq: MBOT) announced the completion of successful discussions with the U.S. Food and Drug Administration (FDA) for its Self-Cleaning Shunt (SCS). After review of the Company’s existing pre-clinical data, the FDA’s feedback will allow the Company to apply for a limited clinical investigation known ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists Microbot MedicalJanuary 21, 2021 GMT HINGHAM, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to enhance its thought leadership capabilities with the addition of several new Scientific Advisory Board (SAB) members: Stephen B. Solomon, MD, a board-certified radiologist with clinical expertise in Interventional Radiology with a focus in Tumor Ablation; Ajay K. Wak...

Microbot Medical Demonstrates Significant Progress in 2020; Outlines Anticipated Milestones for 2021 Microbot Medical Demonstrates Significant Progress in 2020; Outlines Anticipated Milestones for 2021 HINGHAM, Mass., Jan. 11, 2021 — Microbot Medical Inc. (Nasdaq CM: MBOT) has concluded 2020 with the achievement of several operating and developmental milestones. The Company believes it is well positioned to leverage and capitalize upon this momentum through 2021, with plans to execute additional developmental, regulatory and clinical goals. Key 2020 Operational and Product Achievements Off...